- Home
- EDIT vs SEVN Comparison
EDIT vs SEVN Comparison
Compare EDIT & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- SEVN
- Stock Information
- Founded
- EDIT 2013
- SEVN 1986
- Country
- EDIT United States
- SEVN United States
- Employees
- EDIT N/A
- SEVN N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- SEVN Real Estate Investment Trusts
- Sector
- EDIT Health Care
- SEVN Real Estate
- Exchange
- EDIT Nasdaq
- SEVN Nasdaq
- Market Cap
- EDIT 176.7M
- SEVN 198.5M
- IPO Year
- EDIT 2016
- SEVN N/A
- Fundamental
- Price
- EDIT $1.32
- SEVN $12.92
- Analyst Decision
- EDIT Buy
- SEVN Strong Buy
- Analyst Count
- EDIT 14
- SEVN 3
- Target Price
- EDIT $8.08
- SEVN $14.50
- AVG Volume (30 Days)
- EDIT 3.3M
- SEVN 63.0K
- Earning Date
- EDIT 11-04-2024
- SEVN 10-28-2024
- Dividend Yield
- EDIT N/A
- SEVN 10.67%
- EPS Growth
- EDIT N/A
- SEVN N/A
- EPS
- EDIT N/A
- SEVN 1.28
- Revenue
- EDIT $61,759,000.00
- SEVN $30,401,000.00
- Revenue This Year
- EDIT N/A
- SEVN N/A
- Revenue Next Year
- EDIT N/A
- SEVN N/A
- P/E Ratio
- EDIT N/A
- SEVN $10.25
- Revenue Growth
- EDIT 150.95
- SEVN N/A
- 52 Week Low
- EDIT $1.28
- SEVN $11.23
- 52 Week High
- EDIT $11.58
- SEVN $14.66
- Technical
- Relative Strength Index (RSI)
- EDIT 24.88
- SEVN 43.20
- Support Level
- EDIT $1.28
- SEVN $12.85
- Resistance Level
- EDIT $2.37
- SEVN $13.80
- Average True Range (ATR)
- EDIT 0.18
- SEVN 0.43
- MACD
- EDIT -0.04
- SEVN -0.04
- Stochastic Oscillator
- EDIT 6.45
- SEVN 14.85
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.